NCT03907865View on ClinicalTrials.gov

Clinical Efficacy of Topical Hydrocortisone 0.335% (Softacort®) in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 27, 2018

Primary Completion Date

November 28, 2018

Study Completion Date

January 2, 2019

Conditions
Dry Eye
Interventions
DRUG

Softacort

Group 1: 4 times daily for the first 12 days of the treatment period and then 2 times daily for 2 additional days Group 2: 3 times daily for the first 8 days of the treatment period and then 2 times daily for 3 additional days

Trial Locations (1)

1090

Department of Clinical Pharmacology, Medical University Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT03907865 - Clinical Efficacy of Topical Hydrocortisone 0.335% (Softacort®) in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation | Biotech Hunter | Biotech Hunter